Takeda Start Operations at New Research Center
Takeda Pharmaceutical started operations for its newly formed clinical research company, Axcelead Drug Discovery Partners, as of July 1, 2017. Axcelead is the receiving company to which Takeda transferred a part of its research business on May 15, 2017.
Axcelead aims to bridge basic and applied clinical research from exploratory research to optimizing candidate compounds. Axcelead will support not only the Takeda Group businesses but also other life-science organizations such as other pharmaceutical companies, biotechnology ventures, and public and academic research institutions, both within and outside Japan, as part of its integrated drug-discovery services and consultation for the Shonan Health Innovation Park at Takeda’s Shonan Research Center.